Results 141 to 150 of about 34,631 (176)

Clinical outcomes of empirical anti-MRSA therapy at a tertiary care center in Madinah, Saudi Arabia: a retrospective single-center cohort study. [PDF]

BMC Infect Dis
Aljohani F, Suliman K, Alsehemi AF, Kinani E, Alrehaili R, Alkadi L, Alshareef H.   +6 more
europepmc   +1 more source

Co-Infection of <i>Chlamydia psittaci</i> and Methicillin-Resistant <i>Staphylococcus aureus</i> in Community-Acquired Pneumonia - A Case Report. [PDF]

Infect Drug Resist
Zhu SL, Pan LJ, Cheng WB, Zheng XF, Chen Y, Li M.   +5 more
europepmc   +1 more source

Brain Abscess Following CPX-351 Treatment in a Patient With Acute Myeloid Leukemia. [PDF]

Case Rep Hematol
Yamaga Y, Okazaki S, Sakuma Y, Siraisi D, Nishiyama T.   +4 more
europepmc   +1 more source

Pregnant Women With Multidrug-Resistant/Rifampicin-Resistant Tuberculosis and the All-Oral 6-Month Regimen: Experiences From a Patient Series in South Africa. [PDF]

Clin Infect Dis
Loveday M, Clarence E, Hlangu S, Singh N, Chotoo S, Brust JCM, Waitt C, Court R, Furin J.   +8 more
europepmc   +1 more source

Incidence and sex-related risk factors of linezolid-associated adverse drug reactions identified through electronic health records. [PDF]

Transl Clin Pharmacol
Baek S, Oh J, Yoon S, Yoon S, Chung JY.
europepmc   +1 more source

Analysis of the impact of national centralized volume-based procurement drug policy on the market dynamics of tuberculosis drugs. [PDF]

BMC Health Serv Res
Yang J, Yu X, Yao Y, Zhao W, Chen Y, Wang Z, Xu M.   +6 more
europepmc   +1 more source

Correction: Synergistic antibacterial effects of postbiotics combined with linezolid and amikacin against nosocomial pathogens. [PDF]

Front Cell Infect Microbiol
Yaprak Çolak E, Duran N.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Linezolid

Drugs, 2012
Markham Anthony, Anthony Markham, A Markham   +2 more
exaly   +4 more sources

Linezolid

Drugs, 2000
Linezolid is an oxazolidinone antibacterial agent that acts by inhibiting the initiation of bacterial protein synthesis. Cross-resistance between linezolid and other inhibitors of protein synthesis has not been demonstrated. Linezolid has a wide spectrum of activity against gram-positive organisms including methicillin-resistant staphylococci ...
D, Clemett, A, Markham
openaire   +2 more sources

Pharmacoeconomics of linezolid

Expert Opinion on Pharmacotherapy, 2008
New antibiotics efficacious in infections caused by resistant Gram-positive microorganisms and with acceptable costs for national health systems per unit of effectiveness are needed.This paper aimed to summarize all available evidence regarding the pharmacoeconomics of linezolid.A systematic review of pharmacoeconomic analyses through a non-restricted ...
Santiago, Grau, Carlos, Rubio-Terrés
openaire   +2 more sources